{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:34:31Z","timestamp":1761863671365},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.01.039","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T23:00:33Z","timestamp":1486162833000},"page":"1299-1305","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy"],"prefix":"10.1016","volume":"35","author":[{"given":"M.L.","family":"Wumkes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.T.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meerveld-Eggink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.G.","family":"Koopmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.T.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.H.","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.039_b0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.01.039_b0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1345\/aph.1A277","article-title":"Immunization recommendations for adults with cancer","volume":"36","author":"Cooksley","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2017.01.039_b0015","unstructured":"Health Council of the Netherlands. Influenza vaccination: revision of the indication. The Hague: Health Council of the Netherlands, 2007; publication no. 2007\/09E. ISBN 978-90-5549-712-6."},{"key":"10.1016\/j.vaccine.2017.01.039_b0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1345\/aph.1A277","article-title":"Immunization recommendations for adults with cancer","volume":"36","author":"Arrowood","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2017.01.039_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s005200000186","article-title":"Humoral immune response after vaccination against influenza in patients with breast cancer","volume":"9","author":"Brydak","year":"2001","journal-title":"Supp Care Cancer"},{"key":"10.1016\/j.vaccine.2017.01.039_b0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjc.6690342","article-title":"Seroconversion after influenza vaccination in patients with lung cancer","volume":"80","author":"Anderson","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2017.01.039_b0035","first-page":"CR332","article-title":"Influenza vaccination in patients with breast cancer: a case-series analysis","volume":"12","author":"Vilar-Compte","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2017.01.039_b0040","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/annonc\/mdq728","article-title":"Response to influenza virus vaccination during chemotherapy in patients with breast cancer","volume":"22","author":"Meerveld-Eggink","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vaccine.2017.01.039_b0045","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2013.10.053","article-title":"Serum antibody response to influenza virus vaccination during chemotherapy treatment in patients with solid tumours","volume":"31","author":"Wumkes","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.039_b0050","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1200\/JCO.2009.26.6908","article-title":"Utility of influenza vaccination for oncology patients","volume":"14","author":"Pollyea","year":"2010","journal-title":"JCO"},{"key":"10.1016\/j.vaccine.2017.01.039_b0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1469-0691.2011.03701.x","article-title":"Profiling of humoral immune responses to influenza viruses by using protein microarray","volume":"18","author":"Koopmans","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2017.01.039_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0022172400069412","article-title":"Antibody response to immunization with influenza A\/USSR\/77 (H1N1) virus in young individuals primed or unprimed for A\/New Jersey\/76 (H1N1) virus","volume":"87","author":"Masurel","year":"1981","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2017.01.039_b0065","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.vaccine.2009.02.053","article-title":"Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible","volume":"27","author":"Gelinck","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.039_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vaccine.2007.10.049","article-title":"Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6\u20139 and 10\u201313 years","volume":"26","author":"Schmidt-Ott","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.039_b0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/biol.1993.1071","article-title":"Harmonization of requirements for influenza virus vaccines: the first year\u2019s experience with the EEC guideline","volume":"21","author":"Damen","year":"1993","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.01.039_b0080","unstructured":"Committee for Proprieteary Medicinal Products (CPMP) Note for guidance on harmonisation of requirements for influenza vaccines (CPMP\/BWP\/214\/96); 1997."},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.039_b0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/irv.12351","article-title":"A review of the changes to the licencing of influenza vaccines in Europe","volume":"10","author":"Wijnans","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"issue":"11","key":"10.1016\/j.vaccine.2017.01.039_b0090","doi-asserted-by":"crossref","first-page":"e113021","DOI":"10.1371\/journal.pone.0113021","article-title":"Discrimination of influenza infection (A\/2009 H1N1) from prior exposure by antibody protein microarray analysis","volume":"9","author":"te Beest","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.01.039_b0095","doi-asserted-by":"crossref","first-page":"20385","DOI":"10.1038\/srep20385","article-title":"Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemic","volume":"6","author":"Freidl","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.01.039_b0100","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0264-410X(96)00058-8","article-title":"Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults","author":"Beyer","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.039_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virusres.2004.02.024","article-title":"Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?","volume":"103","author":"Beyer","year":"2004","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.039_b0110","doi-asserted-by":"crossref","first-page":"e54890","DOI":"10.1371\/journal.pone.0054890","article-title":"Profiling of humoral response to Influenza A (H1N1) pdm 09 infection and vaccination by a protein microarray in persons with and without history of seasonal vaccination","volume":"8","author":"Huijskens","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.01.039_b0115","first-page":"1","article-title":"A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy","author":"Sanada","year":"2016","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.039_b0120","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.vaccine.2015.12.037","article-title":"Improved immunogenicity of high-dose influenza vaccine compared to standard dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: a pilot randomized clinical trial","volume":"34","author":"Jamhed","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T03:37:09Z","timestamp":1568777829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17300889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17300889"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}